Target intelligence / Profile preview

Streptococcus pneumoniae Polysaccharide Antigens (CPS)

Target
CPS
Molecular classification
Capsular Polysaccharide, Cell Wall Polysaccharide, Bacterial Antigen, Teichoic acid
01

Overview

Streptococcus pneumoniae polysaccharide antigens are complex carbohydrates on the bacterial surface, primarily capsular polysaccharides (CPS), that act as virulence factors by inhibiting phagocytosis. Over 90 serotypes exist, each with a unique CPS structure. These antigens are key targets for vaccines like PPSV23 (purified polysaccharides) and PCV13 (conjugated polysaccharides), which induce protective antibody responses and reduce pneumococcal disease incidence.

Other names
Pneumococcal Capsular PolysaccharidesC-PolysaccharideS. pneumoniae CPSPneumococcal polysaccharide
02

Mechanism of action

Induction of opsonizing antibodies; T-cell dependent B cell activation (PCV13)

03

Biological functions

Immune evasionInhibition of phagocytosisVirulenceB cell activation
04

Disease associations

PneumoniaMeningitisBacteremiaOtitis MediaSinusitisInfection
05

Safety considerations

Limited efficacy in young children (PPSV23)Serotype replacementImmunogenicity in immunocompromised individualsInjection site reactions
06

Interacting drugs

PPSV23 (Pneumovax 23)

1 more in the full profile.

07

Biomarkers

Anti-pneumococcal IgG antibody titersSerotype-specific antibody levels

Beyond the preview

Go deeper on Streptococcus pneumoniae Polysaccharide Antigens (CPS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus pneumoniae Polysaccharide Antigens (CPS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call